Stock listing
APLI Stock Price, News, Filings & Events — Appili Therapeutics Inc Class A
Selected listing: APLI · TSX · CAD · CA
This page tracks Appili Therapeutics Inc Class A's APLI:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APLI:TSX. APLI:TSX is the stock-level entry point for investors researching Appili Therapeutics Inc Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Appili Therapeutics Inc Class A, trading under the ticker APLI, is a public company based in Canada. The company has a market capitalization of approximately CAD 1.41 million. Appili focuses on developing innovative therapies to address unmet medical needs.

- Ticker
- APLI:TSX
- Asset type
- Stock
- Market cap
- $944,035
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD
Appili Therapeutics Inc Class A APLI:TSX stock context
This page tracks Appili Therapeutics Inc Class A's APLI:TSX listing on TSX in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APLI:TSX. APLI:TSX is the stock-level entry point for investors researching Appili Therapeutics Inc Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Appili Therapeutics Inc Class A, trading under the ticker APLI, is a public company based in Canada. The company has a market capitalization of approximately CAD 1.41 million. Appili focuses on developing innovative therapies to address unmet medical needs.
Research Appili Therapeutics Inc Class A
Appili Therapeutics Inc Class A investor report
Review AI stock analysis and investor report context for APLI:TSX.
Appili Therapeutics Inc Class A company profile
View the public company page for Appili Therapeutics Inc Class A on 6ix.
Appili Therapeutics Inc Class A news
Read company news and market updates connected to Appili Therapeutics Inc Class A.
Appili Therapeutics Inc Class A investor events
Find investor webinars, events, and replay context for Appili Therapeutics Inc Class A.